BioWorld-International-2006-05-24
U3 Pharma Raises EUR 27M For Preclinical Cancer Products
U3 Pharma Raises EUR 27M For Preclinical Cancer Products
U3 Pharma AG raised 27 million (US$34.7 million) to accelerate development of its pipeline of targeted therapies, designed to modulate signal transduction pathways in cancer. (BioWorld International)

